Want to track NBY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NovaBay Pharmaceuticals, Inc. (NBY) Statistics
Valuation metrics
Market Cap 39.14M
Enterprise value 18.84M
Trailing P/E (ttm) 0.07
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 14.86
Price/Book (mrq) 0.25
Enterprise Value/Revenue 7.65
Enterprise Value/EBITDA -3.63
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.46M
Average volume (90 days) 326.31K
Price summary
52-Week low 1
52-Week high 99.75
Beta -
50-Day moving average 1.16
200-Day moving average 8.64
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 4
Trailing annual dividend yield 2.963%
5-Year annual dividend yield -
Payout ratio 0.01
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 23 Feb 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 212.18%
Operating margin -2.14%
Operational effectiveness
Return on assets 2.91%
Return on equity 17.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 20.09
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.71
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 5.29%
Book value per share (mrq) 5.34
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
